Literature DB >> 26849831

Impact of catheter size on reliability of quantitative coronary angiographic measurements (comparison of 4Fr and 6Fr catheters).

Shigenori Ito1,2,3, Kanako Kinoshita4, Akiko Endo4, Masato Nakamura4,5, Toshiya Muramatsu4,6.   

Abstract

To evaluate the feasibility of catheter down sizing for QCA, the reliability of a 4Fr catheter as a calibration device was evaluated. Repeated coronary angiograms of 9 lesions were obtained using 4Fr and 6Fr catheters under otherwise identical conditions. The calibration factor was measured 10 times by 4Fr and 6Fr catheters. QCA measurements including minimal lumen diameter (MLD), interpolated normal reference (Int N), percent diameter stenosis (%DS), and lesion length (LL) were performed by two technicians twice with a 3-month interval. The intraobserver and interobserver variability of each parameter was evaluated using intraclass correlation coefficients (ICCs). Mean of mean SD of calibration factor was significantly larger in 4Fr than in 6Fr in 9 lesions. The mean of mean coefficient of variance was significantly larger in 4Fr catheters vs in 6Fr catheters. A 6Fr catheter showed excellent reliability for both intraobserver and interobserver variability in MLD, Int N, %DS, and LL. In contrast, 4Fr showed that reliability in intraobserver variability depended on the analyst. Although reliability of interobserver variability in Int N measured by the 4Fr catheter was >0.80, the value was less than that by the 6Fr catheter. Taking these results into consideration, 4Fr catheters are less reliable than 6Fr catheters when measuring QCA data especially for follow-up data that need most accurate measurements of MLD and %DS. It would be better to use a 6Fr catheter to evaluate QCA measurements such as acute gain, late loss, restenosis rate, and device size.

Entities:  

Keywords:  Catheter size; Core laboratory; Late loss; Minimal lumen diameter; Quantitative coronary angiography

Mesh:

Year:  2016        PMID: 26849831     DOI: 10.1007/s00380-016-0800-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  12 in total

1.  Suitability of the Cordis Stabilizer marker guide wire for quantitative coronary angiography calibration: an in vitro and in vivo study.

Authors:  G Koning; E Hekking; J S Kemppainen; G A Richardson; M T Rothman; J H Reiber
Journal:  Catheter Cardiovasc Interv       Date:  2001-03       Impact factor: 2.692

2.  Validation of 4 French catheters for quantitative coronary analysis: in vivo variability assessment using 6 French guiding catheters as reference scaling devices.

Authors:  Marcelo Sanmartin; Javier Goicolea; Raul Castellanos; Marisol Bravo; Raymundo Ocaranza; Diogenes Cuevas; Ramon Mantilla; Rafael Ruiz-Salmeron
Journal:  J Invasive Cardiol       Date:  2004-03       Impact factor: 2.022

Review 3.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

4.  Variability in estimation of coronary dimensions from 6F and 8F catheters.

Authors:  V Legrand; B Raskinet; C Martinez; H Kulbertus
Journal:  Cathet Cardiovasc Diagn       Date:  1996-01

5.  Zotarolimus-eluting stent utilization in small-vessel coronary artery disease (ZEUS).

Authors:  Man-Hong Jim; Kai-Hang Yiu; Raymond Chi-Yan Fung; Hee-Hwa Ho; Andrew Kei-Yan Ng; Chung-Wah Siu; Wing-Hing Chow
Journal:  Heart Vessels       Date:  2013-02-24       Impact factor: 2.037

6.  Transradial catheterization may decrease the radial artery luminal diameter and impair the vasodilatation response in the access site at late term: an observational study.

Authors:  Ali Buturak; Burak Murat Tekturk; Aleks Degirmencioglu; Sila Ulus; Ozgur Surgit; Cem Ariturk; Ertugrul Zencirci; Sevket Gorgulu
Journal:  Heart Vessels       Date:  2015-02-05       Impact factor: 2.037

7.  Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial.

Authors:  Didier Carrié; Nicolas Delarche; Christophe Piot; Jacques Berland; Nicolas Menneveau; Laurent Bonello; Antoine Py; Emmanuel Teiger; Laurent Leborgne; Gilles Bayet; Olivier Wittenberg; François Schiele
Journal:  EuroIntervention       Date:  2014-10       Impact factor: 6.534

8.  Angiographic assessment of dimensions of 6F and 7F Mallinckrodt Softouch coronary contrast catheters from digital and cine arteriograms.

Authors:  G Koning; P M van der Zwet; C D von Land; J H Reiber
Journal:  Int J Card Imaging       Date:  1992

9.  Angiographic result of T-stenting with small protrusion using drug-eluting stents in the management of ischemic side branch: the ARTEMIS study.

Authors:  Man-Hong Jim; Eugene Brian Wu; Raymond Chi-Yan Fung; Andrew Kei-Yan Ng; Kai-Hang Yiu; Chung-Wah Siu; Hee-Hwa Ho
Journal:  Heart Vessels       Date:  2014-03-14       Impact factor: 2.037

10.  Long-term incidence and prognostic factors of the progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary intervention.

Authors:  Hidehiro Kaneko; Junji Yajima; Yuji Oikawa; Shingo Tanaka; Daisuke Fukamachi; Shinya Suzuki; Koichi Sagara; Takayuki Otsuka; Shunsuke Matsuno; Hiroto Kano; Tokuhisa Uejima; Akira Koike; Kazuyuki Nagashima; Hajime Kirigaya; Hitoshi Sawada; Tadanori Aizawa; Takeshi Yamashita
Journal:  Heart Vessels       Date:  2013-06-27       Impact factor: 2.037

View more
  2 in total

1.  Angiographic study of the clinical liaison of drug-eluting stent and paclitaxel-eluting balloon in unifocal side branch ostium stenosis (ASCLEPIUS).

Authors:  Man-Hong Jim; Eugene Brian Wu; Chi-Yuen Chan; Ka-Lam Wong; Raymond Chi-Yan Fung; Kai-Hang Yiu
Journal:  Heart Vessels       Date:  2017-03-29       Impact factor: 2.037

2.  Inter- and intra-core laboratory variability in the quantitative coronary angiography analysis for drug-eluting stent treatment and follow up.

Authors:  Shigenori Ito; Kanako Kinoshita; Akiko Endo; Ryoko Kami; Yuko Kotake; Masato Nakamura
Journal:  Ther Adv Cardiovasc Dis       Date:  2020 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.